drugset
drugset / Trial / NCT03515694

Minimal Optimal Dose of Sugammadex in Elective Surgery

NCT03515694 ↗

Phase 4 Completed 40 enrolled Erasme University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Time of appearance of TOF Ratio \>0,9 with different doses of Sugammadex

Timeline

Start
2018-04-03
Primary completion
2018-09-30
Completion
2018-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified 0.5 mg/kg Other
Subject Sugammadex Other / unclassified 1 mg/kg Other
Subject Sugammadex Other / unclassified 2 mg/kg Other

Indications

No indication recorded.